212 related articles for article (PubMed ID: 17977605)
1. Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2.
Berini CA; Susana Pascuccio M; Bautista CT; Gendler SA; Eirin ME; Rodriguez C; Pando MA; Biglione MM
J Virol Methods; 2008 Feb; 147(2):322-7. PubMed ID: 17977605
[TBL] [Abstract][Full Text] [Related]
2. Human T lymphotropic virus types I and II proviral sequences in Argentinian blood donors with indeterminate Western blot patterns.
Mangano AM; Remesar M; del Pozo A; Sen L
J Med Virol; 2004 Oct; 74(2):323-7. PubMed ID: 15332282
[TBL] [Abstract][Full Text] [Related]
3. Best screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2 in South America.
Caterino-de-Araujo A
J Virol Methods; 2009 Mar; 156(1-2):150-1. PubMed ID: 18992771
[No Abstract] [Full Text] [Related]
4. [Sero-epidemiological study on the human T-cell leukaemia virus type I/II infection in the east coastal areas of Fujian province].
Wang HR; Yan YS; Zhang QW; Zheng J; Liu JM; Feng YY; Wu SQ; Wu JH
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):428-30. PubMed ID: 15231172
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of commercial equipment used in blood banks in Córdoba for the detection of anti-HTLV-I/II antibodies].
Llop N; Gastaldello R; Valle M; Macedo R; Maturano E; Blanco S; Medeot S; Gallego S
Rev Argent Microbiol; 2000; 32(4):202-5. PubMed ID: 11149153
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a new, fully automated immunoassay for detection of HTLV-I and HTLV-II antibodies.
Qiu X; Hodges S; Lukaszewska T; Hino S; Arai H; Yamaguchi J; Swanson P; Schochetman G; Devare SG
J Med Virol; 2008 Mar; 80(3):484-93. PubMed ID: 18205214
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell lymphotropic virus types I and II (HTLV-I and -II) infection among seroindeterminate cases in Argentina.
Berini CA; Eirin ME; Pando MA; Biglione MM
J Med Virol; 2007 Jan; 79(1):69-73. PubMed ID: 17133550
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new screening assay for HTLV-1 and -2 antibodies for large-scale use.
Malm K; Kjerstadius T; Andersson S
J Med Virol; 2010 Sep; 82(9):1606-11. PubMed ID: 20648617
[TBL] [Abstract][Full Text] [Related]
9. Human T-cell leukemia virus type-I/II (HTLV-I/II) serologic testing: the importance of assaying for the full complement of viral antigens.
Aboulafia DM; Bennett C; Koga H; Keith D; Slamon D
Viral Immunol; 1992; 5(2):105-11. PubMed ID: 1616582
[TBL] [Abstract][Full Text] [Related]
10. [Absence of HTLV-I/II virus circulation in blood donors from the provinces of Santa Fe and Santiago del Estero].
Gastaldello R; Fazzola P; Caeiro L; Maturano E; Perez De Rosas A; Fernandez I; Racca R; Rodriguez MB; Molina M; Alonso S; Gallego S
Rev Argent Microbiol; 2002; 34(2):107-9. PubMed ID: 12180256
[TBL] [Abstract][Full Text] [Related]
11. Antigenic mixture of synthetic peptides for the immunodiagnosis of HTLV I/II infection.
Bocalandro YM; Marin MH; Vallejo RA; Peña LP; León CS; Martínez GR; Tanty CR; Clarke DH; Velázquez SB
J Immunoassay Immunochem; 2004; 25(3):205-14. PubMed ID: 15461383
[TBL] [Abstract][Full Text] [Related]
12. Is seroprevalence of HTLV-I/II among blood donors in India relevant?
Kumar H; Gupta PK
Indian J Pathol Microbiol; 2006 Oct; 49(4):532-4. PubMed ID: 17183844
[TBL] [Abstract][Full Text] [Related]
13. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
Campos KR; Gonçalves MG; Costa NA; Caterino-de-Araujo A
Braz J Infect Dis; 2017; 21(3):297-305. PubMed ID: 28343818
[TBL] [Abstract][Full Text] [Related]
14. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
[TBL] [Abstract][Full Text] [Related]
15. Serological patterns and temporal trends of HTLV-1/2 infection in high-risk populations attending Public Health Units in São Paulo, Brazil.
Jacob F; Santos-Fortuna E; Azevedo RS; Caterino-de-Araujo A
J Clin Virol; 2008 Jun; 42(2):149-55. PubMed ID: 18346935
[TBL] [Abstract][Full Text] [Related]
16. Detection of HTLV-I and -II in Scottish blood donor samples and archive donations.
Davidson F; Lycett C; Jarvis LM; Kerr D; Lumley S; Petrik J; Dow BC
Vox Sang; 2006 Oct; 91(3):231-6. PubMed ID: 16958835
[TBL] [Abstract][Full Text] [Related]
17. [Human T-lymphotrophic virus type I and II--diagnosis and clinical presentation].
Christiansen CB
Ugeskr Laeger; 1994 Dec; 156(51):7663-7. PubMed ID: 7839528
[TBL] [Abstract][Full Text] [Related]
18. Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype.
Morimoto HK; Morimoto AA; Reiche EM; Ueda LT; Matsuo T; Reiche FV; Caterino-de-Araujo A
Rev Inst Med Trop Sao Paulo; 2007; 49(4):225-30. PubMed ID: 17823751
[TBL] [Abstract][Full Text] [Related]
19. Strategies for diagnosis of HTLV-I and -II.
Thorstensson R; Albert J; Andersson S
Transfusion; 2002 Jun; 42(6):780-91. PubMed ID: 12147033
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a combined lysate/recombinant antigen anti-HTLV-I/II ELISA in high and low endemic areas of HTLV-I/II infection.
Vrielink H; Sisay Y; Reesink HW; Woerdeman M; Winkel C; de Leeuw SJ; Lelie PN; van der Poel CL
Transfus Med; 1995 Jun; 5(2):135-7. PubMed ID: 7655577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
